AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trial
Journal name: AYU (Journal of Research in Ayurveda)
Original article title: AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trial
AYU is an internationally recognized quarterly journal dedicated to advancing research in Ayurveda. The journal covers a wide range of topics, including clinical and pharmacological research in Ayurveda's eight branches, herbal remedies, phytochemistry, and ethnomedicine.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
R. Govind Reddy
Rajesh Vithal Gosavi
Babita Yadav
Amit Kumar Rai
Madhuri Prashant Holay
Manisha Talekar
Sophia Jameela
Bhagwan Sahay Sharma
Shruti Khanduri
Rakesh Rana
Arunabh Tripathi
Bhogavalli Chandrasekhararao
Narayanam Srikanth
Kartar S. Dhiman
AYU (Journal of Research in Ayurveda):
(An International Quarterly Journal of Research in Ayurveda)
Full text available for: AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trial
Year: 2020 | Doi: 10.4103/ayu.ayu_14_21
Copyright (license): CC BY-NC-SA 4.0
Download the PDF file of the original publication
Summary of article contents:
Background: The evidence on the efficacy and safety of Ayurveda interventions as an add-on to the standard conventional care for coronavirus disease-2019 (COVID-19) is limited.
Other Science Concepts:
Discover the significance of concepts within the article: ‘AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trial’. Further sources in the context of Science might help you critically compare this page with similair documents:
Control group, Sample size, Ayush 64, Ethical consideration, Adverse drug reaction, Immunomodulatory properties, Randomized controlled study, Perceived Stress Scale, Study participants, Clinical trial registry, Clinical recovery, Intervention group, Interleukin-6, Statistically significant difference, Tumor necrosis factor-alpha, Ayurveda intervention, Randomization, Reverse transcription–polymerase chain reaction, Coronavirus disease-2019, Home isolation, Multicentric study, D-dimer, Safety parameter, Inflammatory marker.